<code id='9437AE5B4E'></code><style id='9437AE5B4E'></style>
    • <acronym id='9437AE5B4E'></acronym>
      <center id='9437AE5B4E'><center id='9437AE5B4E'><tfoot id='9437AE5B4E'></tfoot></center><abbr id='9437AE5B4E'><dir id='9437AE5B4E'><tfoot id='9437AE5B4E'></tfoot><noframes id='9437AE5B4E'>

    • <optgroup id='9437AE5B4E'><strike id='9437AE5B4E'><sup id='9437AE5B4E'></sup></strike><code id='9437AE5B4E'></code></optgroup>
        1. <b id='9437AE5B4E'><label id='9437AE5B4E'><select id='9437AE5B4E'><dt id='9437AE5B4E'><span id='9437AE5B4E'></span></dt></select></label></b><u id='9437AE5B4E'></u>
          <i id='9437AE5B4E'><strike id='9437AE5B4E'><tt id='9437AE5B4E'><pre id='9437AE5B4E'></pre></tt></strike></i>

          entertainment

          entertainment

          author:comprehensive    Page View:686
          Boxes of Wegovy. -- health coverage from STAT
          Bloomberg

          A landmark study that found the blockbuster obesity drug Wegovy reduces the chance of heart problems adds urgency to a basic question in medicine: what exactly is the relationship between weight and health?

          On its face, the result that Wegovy cut the risk of major cardiovascular complications by 20% lends credence to arguments by drugmakers, including Wegovy manufacturer Novo Nordisk, that obesity is a disease and weight loss makes people healthier.

          advertisement

          But researchers and doctors cautioned that the results don’t prove obesity treatments improve heart health solely by helping people lose weight. It’s likely that weight loss is one cause, they said, but there could be other key mechanisms at play independent from Wegovy’s effect on body weight.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          Wikipedia

          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more
          Getting Alzheimer's drug Leqembi to patients can be a challenge
          Getting Alzheimer's drug Leqembi to patients can be a challenge

          BenMargot/APAhostofhurdlesareslowingtheadoptionofthenewAlzheimer’sdrugLeqembi,expertsinvolvedinthetr

          read more
          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more

          After traumatic brain injury, life support decisions can use more time

          Decisionsaboutwithdrawinglifesupportafteratraumaticbraininjuryareoftenmadewithin72hours.EMILYKASK/AF